COVID-19 IMMUNE INDEX

Serial Number 97338443
602

Registration Progress

Application Filed
Mar 30, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

COVID-19 IMMUNE INDEX

Basic Information

Serial Number
97338443
Filing Date
March 30, 2022
Abandonment Date
April 17, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
May 22, 2023
Classes
042 044

Rights Holder

KSL BIOMEDICAL, INC.

03
Address
55 Amherst Villa Road
Cheektowaga, NY 14225

Ownership History

KSL BIOMEDICAL, INC.

Original Applicant
03
Cheektowaga, NY

Legal Representation

Attorney
Kevin D. McCarthy

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

12 events
Date Code Type Description Documents
May 22, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 22, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
May 22, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jan 14, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 14, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 14, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 11, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 8, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 8, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 4, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 2, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical health research services that determine the antibody levels relating to a coronavirus in a patient; preparing a report about the determination of the antibody levels relating to a coronavirus in a patient
First Use Anywhere: Mar 23, 2022
First Use in Commerce: Mar 23, 2022
Class 044
Health care services that determine the antibody levels relating to a coronavirus in a patient; preparing a report about the determination of the antibody levels relating to a coronavirus in a patient
First Use Anywhere: Mar 23, 2022
First Use in Commerce: Mar 23, 2022

Classification

International Classes
042 044